BBPvsARKGETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. ARK Genomic Revolution ETF (ARKG) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.75% for ARKG. BBP is up 33.51% year-to-date (YTD) with +$50M in YTD flows. ARKG performs better with 60.61% YTD performance, and +$136M in YTD flows. Run a side-by-side ETF comparison of BBP and ARKG below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs ARKG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/08/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP ARKG | +5.27%+5.74% | +26.69%+41.47% | +33.51%+60.61% | +51.93%+84.14% | +101.25%+50.72% | +103.38%-43.73% |
| Flows | BBP ARKG | +$5M+$110M | +$20M+$210M | +$50M+$136M | +$62M+$151M | +$68M-$431M | +$61M-$2.19B |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP ARKG | +25.82%+43.03% | +25.10%+44.26% | +24.71%+43.95% | +26.60%+46.35% |
| Max drawdown | BBP ARKG | -9.34%-13.89% | -9.59%-27.52% | -25.54%-46.41% | -37.61%-78.11% |
| Max drawdown duration | BBP ARKG | 39d32d | 48d126d | 292d882d | 586d1825d |
Trading data
BBP | ARKG | |
Last sale 9/9/2026 at 1:30 PM | $105.52 | $46.31 |
| Previous close 09/08/2026 | $106.71 | $46.85 |
| Consolidated volume 09/08/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexBBP | ARKG | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/9/2026 at 1:30 PM
Live
Closed
BBP | ARKG | |
|---|---|---|
| Last price | $105.52 | $46.31 |
| 1D performance | -1.12% | -1.15% |
| AuM | $117.14 M | $1.99 B |
| E/R | 0.34% | 0.75% |
Characteristics
BBP | ARKG | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | VIRTUS Investment Partners | Ark Investment |
| Benchmark | LifeSci Biotechnology Products Index | - |
| N° of holdings | 66 | 31 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | April 2, 2019 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
86.5%
Other
13.5%
ARKG
USA
88.43%
Other
11.57%
Sectors
BBP
Healthcare
98.2%
Other
1.8%
ARKG
Healthcare
97.99%
Other
2.01%
Diversification
BBP
Total weight of top 15 holdings out of 15
26.78%
ARKG
Total weight of top 15 holdings out of 15
75.55%
Top 15 holdings
Data as of July 31, 2026
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
ARKG
10X Genomics, Inc.
9.41%
Twist Bioscience Corp.
7.74%
Tempus AI, Inc.
6.57%
CRISPR Therapeutics AG
6.30%
Personalis, Inc.
5.48%
Absci Corp.
5.15%
Guardant Health, Inc.
4.75%
Illumina, Inc.
4.75%
Eli Lilly & Co.
4.69%
CareDx, Inc.
4.31%
Natera, Inc.
4.14%
Beam Therapeutics, Inc.
3.78%
Compass Pathways Plc
3.26%
Recursion Pharmaceuticals, Inc.
2.63%
Adaptive Biotechnologies Corp.
2.58%
Frequently asked questions about BBP and ARKG
How have the BBP and ARKG ETFs performed in 2026?
As of September 8, 2026, BBP is up 33.51% year-to-date (YTD), while ARKG has returned 60.61%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or ARKG?
Year-to-date, the BBP ETF saw +$50M in flows, compared to +$136M for ARKG.
Which ETF is more volatile: BBP or ARKG?
Over the past year, BBP had a volatility of 25.1%, while ARKG experienced 44.26%.
Which ETF is bigger: BBP or ARKG?
As of September 8, 2026, BBP holds $117.14 M in assets under management (AUM), while ARKG manages $1.99 B.
What sectors do the BBP and ARKG ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, ARKG focuses on Healthcare.
What are the top holdings of the BBP ETF and ARKG ETF?
BBP top holdings include Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc.. ARKG holds in its top three: 10X Genomics, Inc., Twist Bioscience Corp. and Tempus AI, Inc..
Which ETF is more diversified: BBP or ARKG?
BBP holds 66 securities with 26.78% of its assets in the top 15. ARKG has 31 securities and a top 15 weight of 75.55%.
Advertisement
Latest news about BBP & ARKG
Advertisement
